Telomir Pharmaceuticals Inc (TELO) Stock Price

0.595 ▲ +0.0229 (+4.00%)
Open: 0.587 Vol: 321.45K Day's range: 0.5731 - 0.71 Nov 11, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
TELO Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.63▼ 0.62▼ 0.62▼ 0.67▼ 0.85▼
MA10 0.60▼ 0.63▼ 0.63▼ 0.79▼ 1.02▼
MA20 0.68▼ 0.72▼ 0.74▼ 0.91▼ 1.09▼
MA50 0.83▼ 0.88▼ 0.90▼ 1.07▼ 1.22▼
MA100 0.94▼ 1.02▼ 1.04▼ 1.12▼ 1.91▼
MA200 1.09▼ 1.10▼ 1.10▼ 1.20▼ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.003▲ -0.004▼ -0.006▼ -0.036▼ -0.049▼
RSI 30.955▼ 29.760▼ 29.772▼ 15.437▼ 22.834▼
STOCH 55.354     32.745     29.006     9.499▼ 8.446▼
WILL %R -74.190     -80.490▼ -81.969▼ -90.476▼ -95.169▼
CCI -51.773     -77.210     -79.710     -132.927▼ -223.085▼
Latest Filters Detected On TELO
▼ RSI&STOCH $TELO Oversold RSI + Stochastic Set Alert
BBANDS $TELO Bollinger Bands Expanding Set Alert
▲ GAP $TELO Open Gap Up %2 Set Alert
CDL $TELO Harami Candlestick Pattern Detected Set Alert
CDL $TELO Doji Candlestick Pattern Detected Set Alert
Telomir Pharmaceuticals Inc News
InvestorNewsBreaks – Telomir Pharmaceuticals (NASDAQ: TELO) Raises Approximately $5.6 Million in PIPE Financing
Tuesday, October 06, 2026 07:45 AM
Telomir Pharmaceuticals (NASDAQ: TELO) announced an approximately $5.6 million private investment in public equity (PIPE) financing through the issuance of 4,843,300 common shares at $1.16 per share, ...
BioMedNewsBreaks — Telomir Pharmaceuticals (NASDAQ: TELO) Reports Preclinical Telomir-Zn Improvements in Visual Function and Retinal Structure in AMD Model
Thursday, September 17, 2026 07:18 AM
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. Telomir Pharmaceuticals (NASDAQ: TELO) a ...
BioMedNewsBreaks — Telomir Pharmaceuticals (NASDAQ: TELO) Reports Peer-Reviewed Telomir-Zn Data Supporting Phase 1/2 TNBC Program
Monday, August 10, 2026 02:56 AM
Telomir Pharmaceuticals (NASDAQ: TELO) announced the peer-reviewed publication of preclinical data showing Telomir-Zn suppressed tumor growth in prostate and triple-negative breast cancer (“TNBC”) ...
TELO historical stock data
date open high low close volume
11/11/26 0.587 0.71 0.5731 0.595 321,445
10/11/26 0.69 0.699 0.545 0.5721 431,512
09/11/26 0.71 0.73 0.67 0.69 170,530
06/11/26 0.775 0.8499 0.6934 0.7101 152,239
05/11/26 0.832 0.87 0.7801 0.7801 165,703
04/11/26 0.91 0.93 0.855 0.875 235,400
03/11/26 0.94 0.95 0.91 0.91 54,234
02/11/26 0.94 0.96 0.9069 0.9151 58,134
30/10/26 0.96 0.9899 0.7905 0.9352 96,598
29/10/26 0.98 1.01 0.962 0.9642 117,444
Quote Details
52wk Low:0.545
52wk High:1.58
Vol:321.45K
Avg Vol(3m):1.9M
1Y Chng:-55.60%
1M Chng:-49.15%
Add to Watch List
More Information
Index US Composite
Market Cap. 42.15M